Abstract:Abstract Objective: The study aims to quantify differential trends in emergency, outpatient, and inpatient healthcare service utilization among among 2,540,348 patients with and without severe mental illness (SMI) before (January 2017 - December 2019) and during (January 2020 - April 2022) the COVID-19 pandemic, across three distinct cohorts tracked from January 2017 to April 2022, based on their SMI status. Design & Setting: A retrospective cohort study was conducted, utilizing data from Healthix, the second-largest health information exchange in the U.S. Participants: The study population included 2,540,348 patients were categorized by their SMI status as of January 2017 to December 2019 into three groups: Severe Mental Illness 137,801 (5.4%), Other Mental Illness 685,280 (27%), No Mental Illness 1,717,267 (67.6%). Exposures: The primary exposure was the COVID-19 pandemic, with a focus on its impact on mental health and non mental health services. Main Outcomes and Measures: The primary outcome was the rate of utilization of mental health and non mental health services. Results: Among the non-SMI patients, there was a 30% decline in emergency visits from 650,000 pre-COVID to 455,000 post-COVID (OR=0.70, p < 0.001), and outpatient visits decreased by 50% from 1.2 million to 600,000 (OR=0.50, p = 0.002). In contrast, the SMI group witnessed a 20% reduction in outpatient visits from 120,000 to 96,000 (OR=0.80, p = 0.015) and a 40% decrease in inpatient visits from 50,000 to 30,000 (OR=0.60, p = 0.008). Recurrent SMI patients exhibited a 25% decline in emergency visits from 32,000 to 24,000 (OR=0.75, p = 0.03) and a 35% drop in outpatient visits from 40,000 to 26,000 (OR=0.65, p = 0.009). The pandemic influenced the type of disorders diagnosed. Non-SMI patients experienced a 23% rise in anxiety-related disorders (n=80,000, OR=1.23, p = 0.01) and an 18% increase in stress-related disorders (n=70,000, OR=1.18, p = 0.04). SMI patients had a 15% surge in severe anxiety disorders (n=9,000, OR=1.15, p = 0.02) and a 12% uptick in substance-related disorders (n=7,200, OR=1.12, p = 0.05). Recurrent SMI patients showed a 20% increase in anxiety and adjustment disorders (n=6,400, OR=1.20, p = 0.03). SMI patients were more adversely affected by COVID-19, with a higher infection rate of 7.8% (n=45,972) compared to 4.2% (n=131,669) in non-SMI patients (OR=1.88, p < 0.001). Hospitalization rates also followed this trend, with 5.2% (n=30,648) of SMI patients being hospitalized compared to 3.7% (n=115,995) among non-SMI patients (OR=1.41, p = 0.007). Moreover, SMI patients had lower vaccination rates of 45.6% (n=268,888) versus 58.9% (n=1,844,261) among non-SMI patients (OR=0.77, p = 0.019). Conclusions: In conclusion, our findings reveal significant disparities in healthcare service utilization between individuals with Serious Mental Illness (SMI) and those without. Notably, the SMI cohort experienced greater disruptions in service continuity, with a more pronounced decline in both outpatient and inpatient visits. Furthermore, the types of disorders diagnosed among this group also saw a shift, emphasizing the need for specialized care and attention during times of crisis. The higher rates of COVID-19 infection and hospitalization among SMI patients compared to non-SMI patients underscore the urgency of targeted public health interventions for this vulnerable group. The lower vaccination rates in the SMI cohort highlight another layer of healthcare disparity that needs to be urgently addressed. These findings suggest that the pandemic has amplified pre-existing inequalities in healthcare access and outcomes for individuals with SMI, calling for immediate, evidence-based interventions to mitigate these effects and ensure equitable healthcare service provision.

Disparities in Outpatient Visits for Mental Health And/or Substance Use Disorders During the COVID Surge and Partial Reopening in Massachusetts

The Disproportionate Impact of Primary Care Disruption and Telehealth Utilization During COVID-19

Changes in Substance Use Diagnoses in the Great Plains during the COVID-19 Pandemic

Evaluating Gaps in Mental and Non-Mental Services Utilization for Individuals with and without a Severe Mental Illness across New York City during the COVID-19 Pandemic

Unveiling the Disparity and Impact on Healthcare Access and Expenditures during the COVID-19 Pandemic in Mississippi

Disruptions to In-person Medical Visits Across the U.S. During the COVID-19 Pandemic: Evolving Disparities by Medical Specialty and Socioeconomic Status

Emergency Department Access During COVID-19: Disparities in Utilization by Race/Ethnicity, Insurance, and Income

Differences in self-reported disruptions in mental health treatment during COVID-19 in a national household sample: impact of severity of functional impairment

Treatment Interruptions and Telemedicine Utilization in Serious Mental Illness: Retrospective Longitudinal Claims Analysis

Disparities and Medical Expenditure Implications in Pediatric Tele-Mental Health Services During the COVID-19 Pandemic in Mississippi

Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US

Patterns of healthcare utilization according to health equity determinants during the first year of the pandemic at Johns Hopkins Medicine

Disparities in accessing specialty behavioral health services during the COVID-19 pandemic and why we need pediatric integrated primary care

An Examination of Depression Severity and Treatment Adherence among Racially and Ethnically Minoritized, Low-Income Individuals during the COVID-19 Transition to Telehealth

Differential impacts of the COVID-19 pandemic on mental health service access among Medicaid-enrolled individuals

Closing the gap: addressing telehealth disparities across specialties in the sustained pandemic era

Substance Use Emergency Department Visits Among Youths With Chronic Conditions During COVID-19

Can telehealth expansion boost health care utilization specifically for patients with substance use disorders relative to patients with other types of chronic disease?

Substance Use ED Visits Among Youths With Chronic Conditions During COVID-19

Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic

Impact of marginalization on characteristics and healthcare utilization among people with substance use disorder in Ontario, Canada, before and during the COVID-19 pandemic: A cross-sectional study